相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular determinants of the aggregation behavior of α- and β-synuclein
Robert C. Rivers et al.
PROTEIN SCIENCE (2008)
The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis
Aaron D. Gitler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Cellular oligomerization of α-synuclein is determined by the interaction of oxidized catechols with a c-terminal sequence
Joseph R. Mazzulli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Structural characterization of the intrinsically unfolded protein β-synuclein, a natural negative regulator of α-synuclein aggregation
Carlos W. Bertoncini et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Kinetic and structural analysis of the early oxidation products of dopamine -: Analysis of the interactions with α-synuclein
Marco Bisaglia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Brain neutral lipids mass is increased in α-synuclein gene-ablated mice
Gwendolyn Barcelo-Coblijn et al.
JOURNAL OF NEUROCHEMISTRY (2007)
New insights on the nature of the chemical species involved during the process of dopamine deprotonation in aqueous solution:: Theoretical and experimental study
Silvia Corona-Avendano et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2007)
RNA interference-mediated knockdown of α-synuclein protects human dopaminergic neuroblastoma cells from MPP+ toxicity and reduces dopamine transport
Timothy M. Fountaine et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Cytosolic catechols inhibit α-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates
Joseph R. Mazzulli et al.
JOURNAL OF NEUROSCIENCE (2006)
The aggregation and fibrillation of α-synuclein
Anthony L. Fink
ACCOUNTS OF CHEMICAL RESEARCH (2006)
Variations in the unstructured C-terminal tail of interferons contribute to differential receptor binding and biological activity
Michal Slutzki et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
α-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models
Antony A. Cooper et al.
SCIENCE (2006)
Mechanisms of neuronal death in synucleinopathy
Atsushi Takeda et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2006)
Comparison of structure and dynamics of micelle-bound human α-synuclein and Parkinson disease variants
TS Ulmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Scalable molecular dynamics with NAMD
JC Phillips et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
The Amber biomolecular simulation programs
DA Case et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
α-synuclein cooperates with CSPα in preventing neurodegeneration
S Chandra et al.
CELL (2005)
Reversible inhibition of α-synuclein fibrillization by dopaminochrome-mediated conformational alterations
EH Norris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease
L Chen et al.
NATURE NEUROSCIENCE (2005)
Structural characterization of copper(II) binding to α-synuclein:: Insights into the bioinorganic chemistry of Parkinson's disease
RM Rasia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Metal-catalyzed oxidation of α-synuclein -: Helping to define the relationship between oligomers, protofibrils, and filaments
NB Cole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The E46K mutation in α-synuclein increases amyloid fibril formation
EA Greenbaum et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Release of long-range tertiary interactions potentiates aggregation of natively unstructured α-synuclein
CW Bertoncini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mapping long-range interactions in α-synuclein using spin-label NMR and ensemble molecular dynamics simulations
MM Dedmon et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2005)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Causal relation between α-synuclein gene duplication and familial Parkinson's disease
P Ibáñez et al.
LANCET (2004)
Interactions among alpha-synuclein, dopamine, and biomembranes - Some clues for understanding neurodegeneration in Parkinson's disease
JC Rochet et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2004)
Yeast genes that enhance the toxicity of a mutant huntingtin fragment or α-synuclein
S Willingham et al.
SCIENCE (2003)
α-synuclein locus triplication causes Parkinson's disease
AB Singleton et al.
SCIENCE (2003)
Effect of mutant α-synuclein on dopamine homeostasis in a new human mesencephalic cell line
J Lotharius et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Annular α-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes
TT Ding et al.
BIOCHEMISTRY (2002)
Dopamine-dependent neurotoxicity of α-synuclein:: A mechanism for selective neurodegeneration in Parkinson disease
J Xu et al.
NATURE MEDICINE (2002)
Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct
KA Conway et al.
SCIENCE (2001)
Electrostatics of nanosystems: Application to microtubules and the ribosome
NA Baker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
α-synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins
R Sharon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Water and potassium dynamics inside the KcsA K+ channel
L Guidoni et al.
FEBS LETTERS (2000)
Chaperone-like activity of synucleins
JM Souza et al.
FEBS LETTERS (2000)
A Drosophila model of Parkinson's disease
MB Feany et al.
NATURE (2000)
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
KA Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
